QuidelOrtho upgraded to Buy from Neutral at Citi | Nasdaq

Dec 11, 2024 · Citi upgraded QuidelOrtho (QDEL) to Buy from Neutral with a price target of $50, up from $44. The firm cites the company’s "attractive discounted valuation" and management’s …

$50
OFF

QuidelOrtho Upgraded To Buy From Neutral At Citi | Nasdaq

2 weeks from now

Dec 11, 2024 · Citi upgraded QuidelOrtho (QDEL) to Buy from Neutral with a price target of $50, up from $44. The firm cites the company’s "attractive discounted valuation" and management’s …

nasdaq.com

$50
OFF

QuidelOrtho Upgraded To Buy From Neutral At Citi

2 weeks from now

Dec 11, 2024 · Citi upgraded QuidelOrtho to Buy from Neutral with a price target of $50, up from $44. The firm cites the company’s “attractive discounted valuation” and management’s …

businessinsider.com

$50
OFF

Citi Upgrades Quidel Stock To Buy On FY25 Growth Prospects And …

2 weeks from now

Dec 11, 2024 · On Wednesday, Citi upgraded shares of Quidel Corp (NASDAQ: QDEL) from Neutral to Buy, raising the price target to $50 from the previous $44.The firm cites improved …

investing.com

$50
OFF

Citigroup Upgrades QuidelOrtho To Buy, Raises Price Target To $50

2 weeks from now

Dec 11, 2024 · Citigroup analyst Patrick Donnelly upgrades QuidelOrtho (NASDAQ:QDEL) from Neutral to Buy and raises the price target from $44 to $50.

sahmcapital.com

$50.00
OFF

Moody National Bank Trust Division Purchases 21,147 Shares Of ...

2 weeks from now

2 days ago · UBS Group started coverage on shares of QuidelOrtho in a report on Thursday, September 19th. They issued a "neutral" rating and a $50.00 target price on the stock. …

marketbeat.com

$50
OFF

QuidelOrtho Reports Q4 Revenue In Line With Guidance

2 weeks from now

2 days ago · Citi has upgraded Quidel from Neutral to Buy, citing improved management execution and attractive valuation. The firm also raised the price target to $50 from the …

investing.com

7%
OFF

QuidelOrtho's SWOT Analysis: Stock Upgrade Amid Cost Cuts, …

2 weeks from now

Dec 17, 2024 · The company's stock has shown resilience with a 20.7% return over the past six months, reflecting improving market sentiment and recent analyst upgrades. Analysts have …

investing.com

2%
OFF

QuidelOrtho (NASDAQ:QDEL) Trading Down 3.2% - Should You …

2 weeks from now

2 days ago · Citigroup upgraded QuidelOrtho from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $44.00 to $50.00 in a research report on Wednesday, …

marketbeat.com

$57.25
OFF

Cracking The Code: Understanding Analyst Reviews For …

2 weeks from now

Sep 19, 2024 · Analysts have set 12-month price targets for QuidelOrtho, revealing an average target of $57.25, a high estimate of $61.00, and a low estimate of $50.00.

nasdaq.com

$64.00
OFF

RBC Capital Sticks To Their Buy Rating For QuidelOrtho (QDEL)

2 weeks from now

2 days ago · In a report released on January 10, Conor McNamara from RBC Capital maintained a Buy rating on QuidelOrtho (QDEL – Research Report), with a price target of $64.00. The …

businessinsider.com

40%
OFF

QuidelOrtho Faces Strategic Shifts Amid Share Sale

2 weeks from now

Nov 21, 2024 · QuidelOrtho ( ) has shared an update. ... QuidelOrtho upgraded to Buy from Neutral at Citi. ... Related Stocks. QDEL. 44.66-0.18 (-0.40%)

businessinsider.com

6%
OFF

Citigroup Stock Climbs After Posting Q4 Earnings Beat; Announces …

2 weeks from now

23 hours ago · Citigroup (NYSE:C) stock gained 5.6% in Wednesday premarket trading after the megabank posted better-than-expected Q4 results and approved a $20B stock buyback …

seekingalpha.com

$35.31
OFF

QuidelOrtho Faces Strategic Shifts Amid Share Sale - Nasdaq

2 weeks from now

Nov 21, 2024 · QuidelOrtho Corporation is in the spotlight as Carlyle Group’s affiliated stockholder sells over 8 million shares in a secondary offering priced at $35.314 per share, with Goldman …

nasdaq.com

20%
OFF

Netflix Earnings Expectations Stay Buoyant, Says Citi

2 weeks from now

8 hours ago · Netflix upgraded to Buy from Neutral at Seaport Research Netflix (NFLX) Stock Could Rip 20% Higher, Says Top Analyst Netflix price target lowered to $1,040 from $1,065 at …

businessinsider.com

5%
OFF

QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues

2 weeks from now

1 day ago · QuidelOrtho Corporation QDEL recently announced preliminary revenues for fourth-quarter 2024. The preliminary results drove down the shares of the company by 2.5% on Jan. …

nasdaq.com

FAQs about QuidelOrtho upgraded to Buy from Neutral at Citi | Nasdaq Coupon?

Should Citi buy quidelortho (QDEL)?

Citi raised its rating on QuidelOrtho Corporation ( NASDAQ: QDEL) to Buy from Neutral on Monday, citing valuation as the reason for the upgrade at a time when the diagnostic product maker trades ~5% lower over the past three months. ...

Is quidelortho a good buy?

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for QuidelOrtho with a $51.00 average price target. Based on QuidelOrtho’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $727.1 million and a GAAP net loss of $19.9 million. ...

What is the price target for quidelortho?

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Analysts have set 12-month price targets for QuidelOrtho, revealing an average target of $57.25, a high estimate of $61.00, and a low estimate of $50.00. ...

What factors affect quidelortho's financials?

This could be influenced by factors such as growth expectations or operational capacity. Negative Revenue Trend: Examining QuidelOrtho's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -4.22% in revenue growth, reflecting a decrease in top-line earnings. ...

How much did Brian Blaser buy QDEL?

Last month, Brian Blaser, the President and CEO of QDEL bought 6,033.00 shares for a total of $249,826.53. TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. ...